期刊文献+

前列腺癌DU145细胞增殖和克隆形成与延伸因子1α基因表达的关系 被引量:1

Impact of elongation factor 1α expression change on proliferation and clone formation of prostate cancer cell line DU145
原文传递
导出
摘要 目的探讨延伸因子1a(EF-1α)基因表达与前列腺癌细胞株DU145细胞增殖、克隆形成等功能的关系。方法DU145细胞株分3组:对照组(未转染siRNA),转染对照组(转染随机siRNA)和实验组(转染EF-1α—siRNA)。应用RNA干扰技术特异性调低DU145细胞株EF-1α蛋白质水平,并通过蛋白质印迹法验证。应用体外细胞功能分析技术,比较EF-1α蛋白质水平调低后DU145细胞增殖、克隆形成能力的变化和差异。结果应用RNA干扰技术实现了特异性调低前列腺癌细胞株DU145中EF-1α的水平。转染随机siRNA不影响DU145细胞中EF-1α蛋白质水平。调低DU145细胞EF-1α蛋白质水平后,实验组DU145细胞第4~7天增殖率较对照组下降45.9%、53.5%、35.3oA和38.1%(P〈0.05)。实验组DU145细胞形成克隆数较对照组减少67.0%(P〈0.01)。结论调低EF-1α表达水平对前列腺癌细胞增殖、克隆形成等肿瘤相关生物学行为产生负面影响。Ep-1α基因在前列腺癌靶向治疗中可能成为适当的靶基因。 Objective To study the elongation factor 1α(EF-1α) gene functions in prostate cancer cell line DU145 in the aspects of cell proliferation and clone formation by using the RNA interfer- ence technique. Methods DU145 cell lines were divided into control group, transfection control group transfected with scramble siRNA and experimental group transfected with EF-1α siRNA. After transfecting EF-1α siRNA into DU145 cell line, the down-regulation of EF-1α expression in DU145 cell line was confirmed by Western blotting and immunofluorescence staining. Then, the cell proliferation and clone formation assays were carried on in these 3 groups of DU145 cells. Results Compared with controls, the specific down-regulation of EF-1α expression was achieved in experimental group only. Compared with control group, after the down-regualtion of EF-1α in DU145 cell line, the cell proliferation rate decreased from day 4 to day 7 after transfection by 45.9%, 53.5%, 35.3% and 38. 1%, respectively(P〈0.05). The clone formation number in experimental group decreased by 67.0 (P〈0.01). Conclusions The down-regulation of EF-1α has a negative impact on prostate cancer cell proliferation and clone formation. EF-1α might be an appropiate targeting gene in prostate cancer targeting therapy.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2010年第3期203-206,共4页 Chinese Journal of Urology
基金 国家自然科学基金资助项目(C03030305)
关键词 肽延伸因子1 RNA干扰 前列腺肿瘤 克隆 分子 细胞增殖 Peptide elongation factor 1 RNA interference Prostatic neoplasms Cloning,molecular Cell proliferation
  • 相关文献

参考文献10

  • 1Zhu G, Reynolds L, Crnogorac-Jurcevie T, et al. Combina- tion of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene, 2003, 22: 3742-3748.
  • 2Kulkarni G, Turbin DA, Amiri A, et al. Expression of pro tein elongation factor eEF1A2 predicts favorable outcome in breast cancer. Breast Cancer Res Treat, 2007, 102:31- 41.
  • 3朱刚,钟惟德,闫伟,万奔,王建业.体外培养前列腺癌DU145细胞侵袭和迁移能力与EF-1 alpha基因表达的关系[J].中华老年医学杂志,2009,28(1):19-22. 被引量:1
  • 4Edmonds BT, Wyckoff J, Yeung YG, et al. Elongation factor-1α is an overexpressed aetin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci, 1996, 109: 2705- 2714.
  • 5Mohler JL, Morris TL, Ford OH 3rd, et al. Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate, 2002, 51: 247- 255.
  • 6Sharma S, Tammela J, Wang X, et al. Characterization of a putative ovarian oncogene, elongation factor latpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clin Cancer Res, 2007, 13:5889-5896.
  • 7Cao H, Zhu Q, Huang J, et al. Regulation and functional role of eEF1A2 in pancreatic carcinoma. Bioehem Biophys Res Commun, 2009, 27, 380: 11-16.
  • 8Regmi S, Rothberg KG, Hubbard JG, et al. The RACK1 signal anchor protein from Trypanosoma brucei associates with eukaryotic elongation factor 1A: a role for translational control in eytokinesis. Mol Microbiol, 2008, 70: 724-745.
  • 9Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev, 2001, 27:165 - 176.
  • 10Loberg RD, Logothetis CJ, Keller ET, et al. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. J Clin Oncol, 2005, 23: 8232-8241.

二级参考文献11

  • 1朱刚,刘明,万奔.早期前列腺癌的诊断与治疗[J].中华男科学杂志,2005,11(9):693-696. 被引量:31
  • 2Pencil SD, Toh Y, Nicolson GL. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat, 1993, 25: 165-174.
  • 3Zhu G, Reynolds L, Jurcevic TC, et al. Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer. Oncogene, 2003, 22: 3742-3748.
  • 4Zhu G, Gilchrist R, Borley N, et al. Reduction of TSG101 protein has a negative impact on tumor cell growth. Int J Cancer,2004, 109:541-547.
  • 5Shiina N,Gotoh Y, Kubomura N, et al. Microtubule severing by elongation factor 1 alpha. Science, 1994, 266: 282-285.
  • 6Winder SJ, Ayscough KR. Actin-binding proteins. Cell Sci,2005, 118.. 651- 654.
  • 7Romer LH, Birukov KG, Garcia JG. Focal adhesions: paradigm for a signaling nexus. Circ Res, 2006, 98: 606-616.
  • 8Loffek S, Zigrino P, Mauch C. Tumor-stroma interactions: their role in the control of tumor cell invasion and metastasis. J Dtsch Dermatol Ges,2006 4: 496-503.
  • 9Condeelis J. Elongation factor-1 alpha, translation and the cytoskeleton. Trends Biochem Sci, 1995, 20 : 169-170.
  • 10Edmonds BT, Wyckoff J, Yeung YG, et al. Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci,1996, 109:2705-2714.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部